Maternal tiredness and cytokine concentrations in mid-pregnancy by Kaartinen, Miia et al.
Contents lists available at ScienceDirect
Journal of Psychosomatic Research
journal homepage: www.elsevier.com/locate/jpsychores
Maternal tiredness and cytokine concentrations in mid-pregnancy
Miia Kaartinena,⁎, Linnea Karlssonb,c,d, E. Juulia Paavonene,f, Päivi Polo-Kantolag, Juho Peltob,
Niko Nousiainenb, Noora M. Scheininb,h, Mikael Maksimowi, Marko Salmii,j, Hasse Karlssonb,c,h
a Department of Adolescent Psychiatry, University of Tampere and Tampere University Hospital
b FinnBrain Birth Cohort Study, Turku Brain and Mind Center, Department of Clinical Medicine, University of Turku
c Centre for Population Health Research, University of Turku and Turku University Hospital
dDepartment of Child Psychiatry, University of Turku and Turku University Hospital
eNational Institute for Health and Welfare, Helsinki, Finland
f Pediatric Research Center, Child Psychiatry, University of Helsinki and Helsinki University Hospital
g Department of Obstetrics and Gynecology, University of Turku and Turku University Hospital
hDepartment of Psychiatry, University of Turku and Turku University Hospital
iMediCity Research Laboratory, University of Turku
j Institute of Biomedicine, University of Turku
A R T I C L E I N F O
Keywords:
Cytokines
Immunology
Pregnancy
Sleep
Sleep quality
Tiredness
A B S T R A C T
Objective: Sleep disturbances relate to altered levels of inflammatory mediators in general population, but not
much is known about the associations between sleep disturbances and inflammatory mediators during preg-
nancy. The present exploratory study investigated whether insomnia, tiredness, general sleep quality, and in-
sufficient sleep duration during pregnancy relate to the concentrations of maternal peripheral circulating cy-
tokines. As sleep disturbances are frequently observed in mood disorders, the results were controlled for
symptoms of depression and anxiety.
Methods: 137 participants were randomly drawn from a representative FinnBrain Birth Cohort. Serum con-
centrations of selected cytokines were analyzed using Multiplex bead arrays from blood samples drawn at the
gestational week 24. The sleep disturbances were evaluated using the Basic Nordic Sleep Questionnaire.
Depressive and anxiety symptoms were measured with the Edinburgh Postnatal Depression Scale and the anxiety
subscale of the self-rated Symptom Checklist 90, respectively.
Results: Enhanced tiredness was associated with cytokine concentrations of IL-2, IL-10, IL-12, IL-13, and TNF-α.
The observed associations resembled a reversed U-shaped curve rather than being linear. Having a good general
sleep quality was associated with higher logarithmic cytokine concentrations of IL-2, IL-4, IL-6, IL-10, IL-12, IL-
13, and IFN-γ. There was no evidence for associations between insomnia or sleep loss and cytokines.
Conclusions: Maternal subjective tiredness and good general sleep quality were associated with altered levels of
immunological markers during pregnancy. The association was independent from symptoms of depression and
anxiety.
1. Introduction
Sleep disturbances with varying severity are reported by approxi-
mately 84% of women during pregnancy [1]. Pregnancy-related sleep
disturbances include sleep onset insomnia, sleep maintenance in-
somnia, as well as shortening of sleep duration along pregnancy [2,3].
Sleep disordered breathing, especially snoring, is also common [2–4].
Sleep disturbances in pregnancy may result in sleepiness, a subjective
feeling of tiredness associated with increased sleep propensity, during
wake hours [5,6]. Increased rates of fatigue and sleepiness are fre-
quently observed throughout normally progressing pregnancies [4,6,7].
Reportedly, women also take more naps during pregnancy compared to
non-pregnant women [3,4].
Cytokines are signaling proteins of the immune system that are
stimulated by infections and other types of inflammation, psychological
stress, as well as sleep disturbances [8–14]. Cytokines may be further
divided into proinflammatory T-helper 1 lymphocyte produced cyto-
kines (Th1 cytokines, such as IFN-γ, IL-6, and IL-12) and anti-
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inflammatory T helper 2 lymphocyte produced cytokines (Th2 cyto-
kines, such as IL-4 and IL-13), depending on the response they provoke
in the body [13,15]. Th1 cytokines are typically induced in anti-mi-
crobial and autoimmune immune responses, whereas Th2 cytokines
counteract the effects of Th1 cytokines and Th2 cytokines also play a
dominant role in allergic reactions. However, while the traditional
Th1:Th2 dichotomy to classify different cytokines is often used, it is an
oversimplified description of cytokine functions [15].
Pregnancy induces changes in maternal cytokine levels, in order to
prevent fetus rejection [16]. There is a trend for overexpression of Th2
produced anti-inflammatory cytokines in early pregnancy and a shift
towards a Th1 produced proinflammatory cytokine profile when the
pregnancy proceeds towards parturition [17]. For parturition, proin-
flammatory cytokines play a central role as they increase the produc-
tion of prostaglandins and matrix-degrading enzymes that are required
in the process of inducing labor [17]. Higher peripheral concentrations
of certain proinflammatory cytokines, e.g. IL-2, IL-6, IL-12, and IFN-γ,
have been shown to associate with preterm delivery [10,18,19].
In general, sleep disturbances have been related to altered levels of
inflammatory mediators, especially to IL-6, CRP and TNF-α
[8,12,14,20,21], although also contradictory findings have been pub-
lished [22]. Knowledge about possible associations between sleep dis-
turbances and cytokine levels in pregnancy is scarce. Diminished
overall sleep quality in early and late pregnancy has been related to
increased TNF-α and IL-6 concentrations, respectively [10,11]. Dis-
turbances in overall sleep quality have also been associated with in-
creased IL-8 in mid-pregnancy, but only among women with African
American ethnicity [23]. When analyzed in more detail, a prolonged
sleep latency has been related to decreased IL-4 and IL-6 concentrations
in the 2nd trimester, and a shortened sleep duration during the 2nd and
3rd trimester with enhanced IL-6 production in the 3rd trimester
[10,11,23]. Among pregnant women with depression, low sleep effi-
ciency (the ratio of the total sleep duration at night compared to the
time spent in bed) has been shown to relate to higher IL-6, whereas a
greater amount of naps and shorter sleep duration (< 7 h per night)
have been associated with higher TNF-a levels, and with higher IL-8
levels, respectively [24]. As depression may alter cytokine levels, these
results are not easily comparable with those of non-depressed pregnant
women [24–28]. However, the association between decreased sleep
efficiency and enhanced IL-6 production has also been observed among
non-depressed women in late pregnancy [10]. Sample sizes in the
above-mentioned studies have been rather small, and possible con-
founding factors, such as body mass index (BMI) and age, have not been
routinely controlled for.
Our aim was to conduct an exploratory study to investigate whether
insomnia, tiredness, general sleep quality, and insufficient sleep dura-
tion during pregnancy are associated with the concentrations of ma-
ternal peripheral circulating cytokines. Compared to the previous stu-
dies investigating associations between sleep disturbances and
cytokines among pregnant women [10,11,23,24], a wider range of pro-
and anti-inflammatory cytokines was under interest in the present
study. We hypothesized that sleep disturbances, presenting as greater
levels of insomnia, tiredness, and sleep loss, and as lessened general
sleep quality, would be associated with a proinflammatory immune
response. We have previously observed that maternal prenatal symp-
toms of depression and anxiety are positively associated with peripheral
circulating cytokines IL-5, IL-9, and IL-13 in mid-pregnancy [26]. Also,
as sleep disturbances are frequently observed in depression and anxiety,
symptoms of depression and anxiety were controlled for in the present
study [29].
2. Methods
2.1. Participants
The study population has been previously described [26] and,
hence, only a brief description is given here. The study participants
were drawn from a larger population-based pregnancy cohort, the
FinnBrain Birth Cohort Study (www.finnbrain.fi) [31], currently on-
going in Southwest Finland. The first consecutive 150 pregnant women
participating in the cohort and attending the mid-pregnancy laboratory
visit were included as potential subjects in the present study. Exclusion
criteria included acute infection (n=4), any chronic inflammatory
condition or autoimmune disorder (n=6) and use of oral corticoster-
oids (n=1). These exclusion criteria data were gained from the par-
ticipants' self-reports and monitored by the research nurse at the la-
boratory visit. Further, two subjects were excluded due to missing data
in the relevant sleep questionnaires. Thus, after the exclusions, 137
subjects aged from 19 to years 42 were included in the study sample.
The study protocol was approved by the Ethics Committee of
Hospital District of Southwest Finland (ETMK 57/180/2011). The
subjects gave their written informed consent after they received oral
and written information on the study.
2.2. Questionnaires
Data on background and potential confounding variables were
collected via self-report questionnaires delivered to the participants at
gestational week (gwk) 14 or from the Finnish National Birth Register
kept by the National Institute for Health and Welfare (www.thl.fi).
These data included information on maternal alcohol consumption
(frequency and amount), smoking (current smoking yes/no, the number
of cigarettes/day), asthma (yes/no), allergies (yes/no), gestational
diabetes (yes/no), and maternal age at delivery. Maternal pre-preg-
nancy BMI (kg/m2) was collected from maternity clinic records
(missing BMI values were imputed by the study population median
value for four subjects). The level of education was defined as low
(basic education, 9 years), medium (undergraduate studies, vocational
education, 9–12 years), or high (university degree or comparable, over
12 years) [26].
The questionnaires concerning sleep quality and quantity, depres-
sive symptoms and overall anxiety were sent to the participants at gwks
14, 24 and 34, representing the second, and the third trimesters.
Responses concurrent with the collection of venous blood samples (gwk
24) were used for the analyses of the present study. Missing data con-
cerning gwk 24 sleep items were imputed for 13 subjects by using their
responses on gwk 14 questionnaires. The number of missing sleep items
was one or two for ten subjects, and five for one subject. Two subjects
did not have any sleep data from gwk 24, and all their sleep data were
thus derived from gwk 14 questionnaires. The exclusion of the three
subjects whose number of imputed sleep items was five or more did not
change the results. Thus, subjects with imputed sleep item data were
not excluded from the sample.
The characteristics of sleep and sleep disturbances were evaluated
using the Basic Nordic Sleep Questionnaire (BNSQ), which includes 27
sleep related questions [32]. In the present study, BNSQ questions
concerning insomnia symptoms ([1] difficulty falling asleep, [2]
monthly frequency of nocturnal awakenings, [3] daily frequency of
nocturnal awakenings, [4] too early morning awakenings, [5] general
sleep quality), and tiredness symptoms ([1] morning tiredness, [2]
daytime tiredness, [3] napping during the day) were of interest. In-
somnia and tiredness items were rated on a five-point-scale ranging
from [1] never or less than once a month, 2) less than once a week, 3)
1–2 days a week, 4) 3–5 days a week, to 5) daily or almost daily during
the past month. The insomnia score was computed by calculating the
sum score of the following BNSQ items: difficulty falling asleep,
monthly frequency of nocturnal awakenings, daily frequency of noc-
turnal awakenings, too early morning awakenings, and general sleep
quality (Cronbach's alpha 0.71). The tiredness score was computed by
calculating the sum score of the BNSQ items of morning tiredness,
daytime tiredness, and napping during the day (Cronbach's alpha 0.69).
Besides using the insomnia score, general sleep quality was used as an
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independent insomnia variable in subsequent analyses. General sleep
quality was treated as a categorical variable with two categories re-
presenting good, and diminished general sleep quality (scale ranges
1–3, and 4–5, respectively). Sleep duration was measured as actual
sleep duration, preferred sleep duration, and sleep loss. Average actual
sleep duration and preferred sleep duration were inquired by the fol-
lowing BNSQ questions: “How many hours do you usually sleep per
night?” and “How many hours of sleep do you need per night (how
many hours would you sleep if you had the possibility to sleep as long
as you need to)?”, respectively, and expressed in hours. For actual sleep
duration and preferred sleep duration, the responses given with a range
of sleeping hours (e.g. 7–8 h) were transformed into their arithmetic
means (e.g. 7.5 h). Sleep loss was determined by subtracting the actual
sleep duration from preferred sleep duration (hours). For analyses,
sleep loss was divided into two subcategories representing sleep loss
less than 2 h, and sleep loss of at least 2 h.
Depressive symptoms were monitored at gwk 24 with the Edinburgh
Postnatal Depression Scale (EPDS) [33], that is a self-report ques-
tionnaire consisting of 10 items and scored on a 4-point Likert scale
(0–3 points/item), total score thus ranging between 0 and 30. The EPDS
can also be used to study prenatal depression [34,35].
Symptoms of overall anxiety were assessed at gwk 24 with the an-
xiety subscale of the self-rated Symptom Checklist 90 (SCL-90-anx)
[36,37]. The anxiety subscale consists of 10 items scored on a 5-point
Likert scale (0–4 points/item), and the range of the total sum score is
thus 0–40.
2.3. Cytokine concentrations
The venous blood samples for measuring cytokine levels were
drawn on gwk 24 during office hours, i.e. between 8 am and 4 pm.
Blood samples were drawn by venipuncture and serum was separated,
aliquoted and stored at −70 °C until analyses. The cytokine con-
centrations were analyzed in a single assay run using Bio-Plex Pro
Human Cytokine 21- and 27-Plex Assay kits (Bio-Rad, Hercules, CA).
The amount of beads, detection antibodies and streptavidin-phycoery-
thrin conjugate were used at half of their recommended concentrations,
as previously described [26,38–42].
In our previous study, associations between maternal prenatal de-
pressive and anxiety symptoms and concentrations of the cytokines IL-
4, IL-5, IL-6, IL-9, IL-10, IL-12, IL-13, TNF-α, and interferon gamma
(IFN-γ), were investigated [26]. As depression and anxiety are asso-
ciated with sleep disturbances, the aim in the present study was to in-
vestigate if maternal sleep characteristics had independent associations
with these cytokine concentrations during pregnancy [29]. Along with
the aforementioned cytokines, the proinflammatory cytokines IL-1β, IL-
2 and IL-8 were additionally investigated, as they have been previously
reported to have associations with pregnancy complications and sleep
problems or disorders [8,15,24]. IFN-γ/IL-4 ratio was calculated to il-
lustrate a rough estimate of the Th1/Th2 balance [43].
2.4. Statistical analyses
2.4.1. Depressive and anxiety symptoms
As the study participants were recruited from the general
Fig. 1. Associations between cytokine concentrations and the tiredness score (95% (pointwise) confidence bands marked with grey colour).
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population, where the frequency of possible clinical depression was
expectedly low, a continuous total sum score of the Edinburgh Postnatal
Depression Scale (EPDS) [33] was used as a measure of depressive
symptoms in the main analyses. For the same reason, a continuous sum
score of the SCL-90 anxiety subscale (SCL-90-anx) [36,37] was used to
measure the level of anxiety among the participants.
2.4.2. Cytokines
Logarithmic transformations of measured cytokine levels were used
in the analyses to reduce skewness of distributions.
2.4.3. Associations between cytokines and the sleep variables
Standard linear regression analysis was used to study associations
between the cytokines and the sleep variables. First, regression analysis
was conducted separately for every cytokine under interest by using
(the natural logarithm of) the cytokine concentration as the dependent
variable, and the tiredness score, the insomnia score, the dichotomous
sleep loss and the selected covariates (BMI, age, depressive and anxiety
symptoms) as independent variables. Associations between the tired-
ness score and each cytokine were modeled by natural cubic splines
[44] with two degrees of freedom to be able to model the non-linear
associations between them (see Fig. 1). To investigate possible asso-
ciations between cytokines and general sleep quality, similar regression
analysis was conducted for every cytokine under interest by using the
dichotomous general sleep quality and the selected covariates as in-
dependent variables. Covariate selection was conducted according to
the observed associations between potential covariates (depressive
symptoms, symptoms of anxiety, age, and BMI) and cytokines in our
previous study [26]. Additionally, in a large-scale population study IL-
2, IL-5, IL-10, IL-12, IL-13, and TNF-α have been associated with BMI
among non-pregnant women [41]. Additionally, age is linked with
some peripheral cytokine profiles [26,45]. As the present study is
among the first to investigate a larger set of cytokines in the context of
maternal prenatal sleep characteristics, these analyses were considered
explorative and the significance level was set at the p value of 0.05. All
the analyses were made using R [46] with the packages ggplot2 [47] for
Fig. 1 and splines [46] for fitting natural cubic spline curves.
3. Results
3.1. Description of the study population
The study population characteristics and descriptive statistics of the
sleep and cytokine variables are presented in Tables 1, 2, and 3, re-
spectively.
3.2. Insomnia
In the regression analyses, the insomnia score was not associated
with any logarithmic cytokine concentration (Table 4).
3.3. Sleep quality
In all, 121 (88.3%) women reported having good, and 16 (11.7%)
women diminished general sleep quality. Having a good general sleep
quality was associated with higher logarithmic cytokine concentrations
of IL-2, IL-4, IL-6, IL-10, IL-12, IL-13, and IFN-γ (Table 5).
3.4. Tiredness
The tiredness score was associated with cytokine concentrations of
IL-2, IL-10, IL-12, IL-13, and TNF-α (Table 4). As seen in Fig. 1, the
observed associations between the tiredness score and logarithmic cy-
tokine concentrations resembled a reversed U-shaped curve rather than
linear (Fig. 1).
3.5. Sleep loss
105 (76.6%) women had sleep loss less than 2 h, and 32 (23.4%)
women more than 2 h. The amount of sleep loss did not relate to cy-
tokine concentrations (Table 4).
3.6. Covariates
In the models where the three sleep score variables (insomnia score,
tiredness score, sleep loss) were entered simultaneously, no associations
between IL-2, IL-10, IL-12, IL-13, or TNF-α logarithmic cytokine con-
centrations and the selected covariates, i.e. depressive symptoms
(p= .074–0.95), anxiety symptoms (p= .45–0.82), age
(p= .078–0.50), or BMI (p= .071–0.67), were observed.
When analyzing the associations between general sleep quality and
the cytokine concentrations, age was related to IL-10 (p= .019), and
IL-12 (p= .031), and BMI to IL-12 (p= .050), and IL-13 (p= .030).
Table 1
Characteristics of the study population (n=137).
Mean (SD) or n (%) Range
Age (years) 30.6 (4.8) 19–42
BMI (kg/m2) 25.2 (4.8) 18–46
Parity
Nulliparous 69 (50.4)
Multiparous 68 (49.6)
Education
Low level 50 (36.5)
Middle level 36 (26.3)
High Level 51 (37.2)
Marital statusa
Married/cohabitating 131 (98.5)
Divorced 0 (0.0)
Single 2 (1.5)
Widowed 0 (0.0)
Asthma 9 (6.6)
Allergy 57 (41.6)
Gestational diabetes 28 (20.4)
Smoking during pregnancy
Non-smokers 122 (89.1)
Smokers 15 (10.9)
Alcohol consumption during pregnancy
Non-users 112 (81.8)
Any use 25 (18.2)
EPDS score 4.38 (3.56) 0–16
SCL-90/anxiety score 2.96 (3.09) 0–15
EPDS= the Edinburgh Postnatal Depression Scale.
SCL= Symptom Checklist 90.
a Four missing values.
Table 2
Characteristics of sleep (BNSQ= the Basic Nordic Sleep Questionnaire)
(n= 137).
Mean (SD) Range
Insomnia score 13.0 (3.3) 5–23
Difficulty falling asleep 1.8 (0.8) 1–4
Monthly frequency of nocturnal awakenings 4.4 (1.0) 1–5
Daily frequency of nocturnal awakenings 2.7 (0.9) 1–5
Too early morning awakenings 2.0 (1.0) 1–5
General sleep quality 2.1 (1.0) 1–5
Tiredness score 7.5 (2.6) 3–15
Morning tiredness 2.6 (1.2) 1–5
Daytime tiredness 2.6 (1.1) 1–5
Napping during the day 2.3 (1.1) 1–5
Sleep Duration
Actual length of sleep (hours) 7.8 (0.9) 6–11
Preferred duration of sleep (hours) 8.9 (1.1) 6–13
Sleep loss 1.1 (1.2) -2 - 5
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4. Discussion
Our hypothesis of an association between maternal prenatal sleep
disturbances and peripheral pro-inflammatory cytokine concentrations
was supported partially. Both tiredness and the general sleep quality
had associations with IL-2, IL-10, IL-12, and IL-13. Additionally,
tiredness was related to TNF-α and the general sleep quality was as-
sociated with IL-4, IL-6, and IFN-γ concentrations. To our best knowl-
edge, this is the first time when associations between maternal prenatal
tiredness and these cytokines have been reported.
There are earlier findings on the association between poor sleep
quality and enhanced inflammatory processes in all phases of preg-
nancy [10,11,23]. Conflicting these findings, good general sleep quality
was related to heightened IL-2, IL-4, IL-6, IL-10, IL-12, IL-13, and IFN-γ
cytokine levels in mid-pregnancy in the present study. Discrepancy
between the results could be at least partly explained by differences in
methodology. In the previous studies, overall sleep quality has been
measured by a total score in the Pittsburgh Sleep Quality Index (PSQI),
which includes variety of sleep disturbance items, while in the present
study general quality of sleep was measured as a subjective estimation
of sleep quality [10,11,23]. There is an earlier study showing that
compromised subjective quality of sleep relates to enhanced IL-6 pro-
duction while stimulated with Escherichia coli endotoxin [10]. Ac-
cording to the results of the present study, positive associations be-
tween good subjective sleep quality and cytokines might also be present
without any stimulation and concern wider range of cytokines that
earlier observed.
Previous studies have also yielded scattered evidence that also
prolonged sleep latency, poor sleep continuity, and shortened sleep
duration relate to altered levels of immunological responses during
pregnancy [10,11,23,24]. However, insomnia or sleep loss were not
associated with the level of peripheral cytokines in the present study,
where depressive symptoms, the level of anxiety, BMI, and age were
controlled for. This implies that similarly as among non-pregnant
women, also during pregnancy disturbed sleep in general may not re-
late to altered immunological responses [48]. Different types of sleep
disturbances may represent distinctive phenotypes that correspond
with differential immunological mechanisms, and for example, may
rather relate to a disturbed Th1/Th2 balance, than to isolated altered
cytokine concentrations [49]. A mediating agent in these associations
might be melatonin that,−besides to the sleep-wake rhythm-, is shown
also to regulate immunological processes on a larger scale [50].
Approximately one-fourth of pregnant women report sleepiness in
mid- and late pregnancy [6]. While the frequency of sleep disturbances
increases as the pregnancy proceeds, the frequency of sleepiness seems
to remain stable over mid- and late pregnancy [6]. Thus, it is possible
that sleepiness in pregnancy may not totally result from disrupted sleep
[6]. Inflammatory mechanisms, especially cytokine IL-6, have been
related –in non-pregnant populations- to daytime fatigue in the absence
and the presence of medical conditions, e.g. multiple sclerosis and
cancer [51–54]. According to the present study, inflammatory me-
chanisms may relate to increased tiredness or subjective tiredness also
in pregnancy. As pregnant women experience more tiredness than non-
pregnant women, our notion that the increased tiredness even in this
population is associated with a distinct peripheral inflammatory marker
pattern, is interesting and potentially important [5,6].
Even though cytokines relate strongly and widely to each other and
to CRP, a multivariate model showed that they rather function as in-
dependent risk factors than relate to tiredness and good general sleep
quality as a solid group [41]. The role of cytokines IL-1 and TNF-alfa as
sleep promotors has been well documented [55,56]. Evidence also
suggests that other cytokines regulate the sleep-wake rhythm [55]. For
an example, whereas IL-1, IL-2, IL-6, and IL-8 promote sleep, IL-4, IL-
10, and IL-13 seem to reduce sleep by inhibiting the production of sleep
promoting cytokines [55]. However, the roles of individual cytokines in
sleep regulation seem to be complex, as in certain concentration one
cytokine may function as a sleep promoter and in another as a sleep
inhibitor [55,56]. Interestingly, the observed associations between
peripheral cytokines and tiredness were not linear, but rather re-
sembled a reversed U-shaped curve. An earlier observation has also
shown that the association between IL-1 and sleep propensity might
resemble a reversed U-shaped curve; i.e. whereas in general IL-1 is a
sleep inductor, in high doses it becomes a sleep inhibitor [56]. It is
possible that a negative feedback-loop regulates the level of circulating
cytokines by decreasing production of previously overproduced per-
ipheral cytokines in case of prolonged Th1 and Th2 cell responses [57].
Also, prolonged or frequent tiredness may induce or result from chronic
stress that –via for instance cortisol dysfunction- has potential to pro-
duce inflammatory responses that are distinct from inflammatory re-
sponses related to short exposure to stressful events [58]. Although the
mechanisms behind the observed U-shaped association between tired-
ness and peripheral cytokines were out of the scope of the present
study, to our knowledge this is a novel finding regarding a range of
cytokines, and warrants further investigation.
In non-pregnant populations, disrupted sleep is related to various
negative health consequences, such as increased risk for diabetes, ele-
vated blood pressure and obesity [59,60]. Growing evidence suggests
that also maternal prenatal sleep disturbances may indicate an in-
creased risk for pregnancy and delivery complications. Insomnia,
shortened sleep duration and sleep deprivation, sleepiness, and de-
creased sleep quality are reportedly associated, for example, with pre-
term labor and preeclampsia, as well as longer delivery and operative
deliveries, especially caesarean sections [23,61–69]. Possible mechan-
isms that mediate the above-mentioned risks may include elevated le-
vels of stress hormones, inflammatory parameters and cytokines, that
have been observed among individuals with sleep disturbances
Table 3
Cytokine concentrations (pg/mL) (n= 137).
Mean (SD)a Range Median Q1/Q3
IL-1β 1.7 (0.2) 3.1–15.8 5.3 4.7/6.3
IL-2 3.0 (0.3) 7.9–74.5 20.8 17.5/23.3
IL-4 2.5 (0.1) 7.4–18.7 13.0 11.6/14.3
IL-5 1.8 (0.3) 3.2–16.4 5.8 4.8/6.9
IL-6 2.7 (0.3) 7.5–80.0 14.0 11.7/16.4
IL-8 3.5 (0.3) 19.0–169.7 30.6 27.6/35.6
IL-9 4.2 (0.7) 28.5–9213.3 59.2 48.3/79.5
IL-10 2.1 (0.5) 2.0–33.6 7.5 6.0/10.6
IL-12 3.3 (0.6) 9.6–249.5 23.7 19.9/34.5
IL-13 2.7 (0.4) 6.4–46.9 14.2 11.3/17.8
TNF-α 4.2 (0.4) 31.8–382.1 62.5 56.2/76.4
IFN-γ 5.6 (0.2) 148.2–609.2 258.3 230.4/295.6
IFN-γ/IL-4 20.7 (2.9) 6.1× 10^6–2.6×10^15 8.0×10^8 1.9×10^8/2.6×10^9
a The means and standard deviations are calculated for logarithm transformed values, others from original values.
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[12,13,22,23,67,68,70]. In our population, multivariable analyses
showed that maternal subjective tiredness and good general sleep
quality explained certain cytokine levels after controlling for the effects
of depressive and anxiety symptoms. However, the present study does
not provide any information on the potential causality of the relation-
ships.
4.1. Strengths and limitations
Our study was merited by a randomly selected sample representing
a generally healthy female population. As the population was relatively
healthy in terms of psychiatric symptoms, extension of our findings to
psychiatric populations needs further research. The sample size in the
present study is larger than in previous studies among pregnant women.
However, even larger samples with repeated assessments would further
strengthen power of the study. The present study should also be con-
sidered as exploratory, and future studies are needed to investigate
associations between cytokines and sleep disturbances in pregnancy.
Immunological responses relating to sleep disturbances seem to vary
according to the phase of pregnancy, and between women with dif-
ferent ethnicities [10,11,23,24]. In addition, cortisol levels were not
measured from the participants. This should be considered as a lim-
itation as cortisol is an important modulator of both, the immune
system, as well as the sleep-wake rhythm [55,58].
Another strength of this study was the broader range of cytokines
compared to previous studies. However, we studied only a single cy-
tokine sample at one time point during the second trimester, which
precludes any conclusions on causality or the sequence of the phe-
nomena, and may hinder comparisons to other studies [11]. The blood
samples were taken during office hours and detailed data on the timing
of individual samples was not available. This can be considered as a
limitation, as some cytokines are secreted with diurnal fluctuations
[71].
The questionnaire we used, the BNSQ, is validated and widely used
in different populations [32]. It contains a wide panel of sleep items and
therefore provides precise information on sleep disturbances and
tiredness. Further studies using objective measures might give new
perspectives into the understanding of the connections between sleep
and inflammation. Previously, we reported that cigarette smoking was
unrelated to cytokine concentrations in this population of pregnant
women with a very low number of cigarette smokers and a low number
of cigarettes consumed/day [26] and thus our results were not con-
trolled for smoking. This precludes the extension of the results to more
Table 4
Results of regression analyses examining the associations between the selected
sleep variables and cytokines (n= 137). All models included all three sleep
parameters (insomnia score, tiredness score, and sleep loss).
B SE B t128⁎/F2, 128⁎⁎ p
IL-1β
Insomnia score 0.001 0.008 0.18⁎ 0.86
Tiredness score (2 df)a 2.84⁎⁎ 0.062
Sleep loss (Ref= ‘No’) −0.084 0.057 −1.47⁎ 0.14
IL-2
Insomnia score −0.012 0.009 −1.41⁎ 0.16
Tiredness score (2 df)a 4.86⁎⁎ 0.009
Sleep loss (Ref= ‘No’) −0.058 0.066 −0.87⁎ 0.39
IL-4
Insomnia score −0.006 0.004 −1.29⁎ 0.20
Tiredness score (2 df)a 2.77⁎⁎ 0.067
Sleep loss (Ref= ‘No’) −0.030 0.034 −0.87⁎ 0.39
IL-5
Insomnia score −0.003 0.009 −0.30⁎ 0.76
Tiredness score (2 df)a 1.99⁎⁎ 0.14
Sleep loss (Ref= ‘No’) −0.103 0.066 −1.56⁎ 0.12
IL-6
Insomnia score −0.018 0.010 −1.70⁎ 0.091
Tiredness score (2 df)a 2.55⁎⁎ 0.082
Sleep loss (Ref= ‘No’) −0.121 0.079 −1.53⁎ 0.13
IL-8
Insomnia score −0.010 0.009 −1.06⁎ 0.29
Tiredness score (2 df)a 1.96⁎⁎ 0.15
Sleep loss (Ref= ‘No’) −0.077 0.069 −1.11⁎ 0.27
IL-9
Insomnia score −0.020 0.023 −0.86⁎ 0.39
Tiredness score (2 df)a 0.73⁎⁎ 0.48
Sleep loss (Ref= ‘No’) −0.214 0.174 −1.23⁎ 0.22
IL-10
Insomnia score −0.006 0.014 −0.44⁎ 0.66
Tiredness score (2 df)a 4.91⁎⁎ 0.009
Sleep loss (Ref= ‘No’) −0.117 0.105 −1.11⁎ 0.27
IL-12
Insomnia score −0.026 0.016 −1.61⁎ 0.11
Tiredness score (2 df)a 4.00⁎⁎ 0.021
Sleep loss (Ref= ‘No’) −0.124 0.121 −1.02⁎ 0.31
IL-13
Insomnia score −0.013 0.010 −1.28⁎ 0.20
Tiredness score (2 df) 4.89⁎⁎ 0.009
Sleep loss (Ref= ‘No’) −0.110 0.079 −1.41⁎ 0.16
TNF-α
Insomnia score −0.020 0.012 −1.71⁎ 0.090
Tiredness score (2 df)a 3.35⁎⁎ 0.038
Sleep loss (Ref= ‘No’) −0.150 0.089 −1.68⁎ 0.095
IFN-γ
Insomnia score −0.007 0.006 −1.11⁎ 0.27
Tiredness score (2 df)a 2.37⁎⁎ 0.098
Sleep loss (Ref= ‘No’) −0.079 0.048 −1.64⁎ 0.10
IFN-γ/IL-4
Insomnia score −0.039 0.088 −0.44⁎ 0.66
Tiredness score (2 df)a 0.41⁎⁎ 0.67
Sleep loss (Ref= ‘No’) −1.063 0.664 −1.60⁎ 0.11
B=Unstandardized regression coefficient. For Sleep loss: the estimated dif-
ference in the (average) log-transformed cortisol levels between the groups with
sleep loss (≥ 2 h) and with no sleep loss (< 2 h). For Insomnia: The effect of
one unit change in the insomnia score on the average log-transformed cortisol
level.
SE B=Standard error (of the regression coefficient) t128=t statistic (with 128
degrees of freedom).
F2, 128=F statistic (with 2 and 128 degrees of freedom).
All models were adjusted for maternal symptoms of depression (EPDS), anxiety
(SCL-90/anxiety), age, and pre-pregnancy body mass index (BMI).
a The result from comparing the model with and without the two spline
terms modeling the non-linear relationship between the Tiredness score and
(average) log-transformed cytokine levels.
Table 5
Results of regression analyses examining the associations between the general
sleep quality and cytokines (n=137).
General sleep quality (Ref= ‘Diminished’)
B SE B t128 p
IL-1β 0.079 0.070 1.13 0.26
IL-2 0.167 0.081 2.06 0.041
IL-4 0.103 0.041 2.51 0.013
IL-5 0.133 0.080 1.65 0.10
IL-6 0.209 0.097 2.16 0.033
IL-8 0.153 0.084 1.83 0.070
IL-9 0.406 0.210 1.94 0.055
IL-10 0.257 0.129 2.00 0.048
IL-12 0.392 0.148 2.66 0.009
IL-13 0.292 0.095 3.07 0.003
TNF-α 0.159 0.111 1.44 0.15
IFN-γ 0.129 0.059 2.18 0.031
IFN-γ/IL-4 0.721 0.804 0.90 0.37
B=Unstandardized regression coefficient. The estimated difference in the
(average) log-transformed cortisol levels between the groups good and dimin-
ished sleep quality.
SE B=Standard error (of the regression coefficient) t128=t statistic (with 128
degrees of freedom).
All models were adjusted for maternal symptoms of depression (EPDS), anxiety
(SCL-90/anxiety), age, and pre-pregnancy body mass index (BMI).
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frequently smoking populations.
5. Conclusions
Maternal subjective tiredness and good general sleep quality were
associated with altered levels of immunological markers during preg-
nancy, the association being independent from symptoms of depression
and anxiety. Based on earlier research, cytokine profiles might affect
the course of pregnancy and delivery, as well as offspring health out-
comes, which underlines the importance of further research in this area
[62,64,67,68,72]. While optimal sleep patterns during pregnancy are
not known and probably vary between women, subjective tiredness and
general sleep quality may present important indicators of a risk of al-
tered inflammatory responses during pregnancy [62].
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